Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

UNITED THERAPEUTICS (UTHR) EBT: 2009-2024

Historic EBT for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $1.5 billion.

  • UNITED THERAPEUTICS's EBT rose 12.71% to $438.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year increase of 15.89%. This contributed to the annual value of $1.5 billion for FY2024, which is 20.77% up from last year.
  • UNITED THERAPEUTICS's EBT amounted to $1.5 billion in FY2024, which was up 20.77% from $1.3 billion recorded in FY2023.
  • In the past 5 years, UNITED THERAPEUTICS's EBT ranged from a high of $1.5 billion in FY2024 and a low of $593.9 million during FY2021.
  • In the last 3 years, UNITED THERAPEUTICS's EBT had a median value of $1.3 billion in 2023 and averaged $1.3 billion.
  • In the last 5 years, UNITED THERAPEUTICS's EBT soared by 487.21% in 2020 and then decreased by 7.04% in 2021.
  • Yearly analysis of 5 years shows UNITED THERAPEUTICS's EBT stood at $638.9 million in 2020, then decreased by 7.04% to $593.9 million in 2021, then skyrocketed by 60.06% to $950.6 million in 2022, then skyrocketed by 34.05% to $1.3 billion in 2023, then rose by 20.77% to $1.5 billion in 2024.